Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s preventative antibody shot ...

Currently, Merck stock shows potential for another collar setup, with defined risk and reward, though I haven't executed a ...

One of the new members to the CDC's vaccine advisory panel has served as an expert witness in a case against Merck's (MRK) ...

JNJ edges ahead of MRK with stronger 2025 growth prospects, a broader pipeline and better sales momentum despite key headwinds.

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

In a report released today, Carter Gould from Cantor Fitzgerald reiterated a Hold rating on Merck & Company (MRK – Research Report), with a price target of $85.00. The companys ...

Merck (MRK) stock was on the move Monday after the healthcare company announced positive results from two Phase 3 clinical trials. These studies saw meaningful reductions in LDL-C from patients with ...

The Dow Jones Industrial Average (DJINDICES: ^DJI) index edged 3.9% higher in May, with 70% of its 30 constituent stocks ...

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...

One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an ...